Brazil health regulation "bundling" triggers Anvisa rethink
This article was originally published in Clinica
Executive Summary
Brazil's ongoing devolution of healthcare regulation is seeing state and municipal healthcare authorities tending to merge the five tiers of health-related surveillance. So said Maria Cecília Martins Brito, director of national agency Anvisa, last week, at the end of a two-day conference of healthcare leaders, held to "discuss the necessity and the options" for better linking the healthcare elements at a local level. The five components of Brazil's health-related regulation are: healthcare, epidemiology, environmental, nutritional and health & safety at work.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.